Ala. Admin. Code r. 680-X-2-.21 - Patient Counseling
(1)
Pharmacists, because of their strategic position in the health care system,
have traditionally provided drug information to their patients and to other
health care professionals. In the best interest of the public health, the
patient must be offered counseling for all new prescriptions and, where
appropriate, for refill prescriptions. The offer to counsel shall be made by
the pharmacist or the pharmacist's designee in a face to face oral
communication with the patient or the patient's representative, unless in the
professional judgment of the pharmacist, it is deemed inappropriate or
unnecessary. If it is deemed inappropriate or unnecessary by the pharmacist, it
would be permissible for the offer to counsel to be made in a written
communication, by telephone, or in a manner determined by the pharmacist to be
appropriate. Said counseling must be performed by the pharmacist or properly
supervised pharmacist intern. A printed statement shall be included with every
prescription listing the pharmacy's telephone number, for the patient to call
with questions about their medication.
(2) Each new prescription and, where
appropriate, refill prescription, should be reviewed for, but not limited to,
the following:
(a) therapeutic
duplication;
(b) drug-disease
contraindication where indicated;
(c) drug-drug interaction;
(d) incorrect dosage/duration;
(e) drug allergy interactions; and
(f) clinical abuse/misuse.
(3) the following: Pharmacists may
discuss, but are not limited to,
(a) Name and
description of the medication;
(b)
Dosage form, dosage, route of administration and duration of therapy;
(c) Special directions, precautions for
preparation, administration and use by the patient;
(d) Common severe side effects, adverse
effects or interactions, and therapeutic contraindications;
(e) Techniques for self-monitoring;
(f) Proper storage;
(g) Refill information; and
(h) Action in the case of missed
dose.
(4) Pharmacists or
the pharmacist's designee, in a face to face communication, in institutional
settings, shall offer to give an oral consultation with all new prescriptions
and, where appropriate, for refill prescriptions dispensed to homeward-bound
patients or the patient's representative. Said counseling must be performed by
the pharmacist or properly supervised pharmacist intern. If the patient or the
patient's representative are unavailable, the pharmacist shall make known the
fact that a consultation is available and how he/she may be reached.
(5) Each pharmacy shall maintain patient
medication profiles.
(6) Patient
Medication Profiles shall be maintained in accordance with state and federal
requirements. A pharmacist or pharmacist's designee shall, verbally or in
writing, make a reasonable effort to obtain information for the patient
medication profile. Each profile shall include a least the following
information, when available:
(a) Patient name,
age, gender, address and phone number;
(b) Individual patient history, including a
list of prescription medications and devices, where appropriate; and
(c) Pharmacist comments.
(7) Supervising pharmacists/directors shall
be responsible to the Board for the provision of the rule.
(8) Each pharmacy shall have the latest
edition and/or revision of "Facts and Comparisons" or any reference book or
electronic media sufficient to meet the level of its pharmacy
practice.
(9) Nothing in this rule
shall prohibit the pharmacist from charging, and being reimbursed, for the
provision of the above described professional service. The pharmacist should
identify any fee for counseling in an itemized bill.
Author: Jerry Moore, Executive Secretary
Notes
Statutory Authority: Code of Ala. 1975, ยง 34-23-92.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.